These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20927134

  • 21. C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics.
    Lu Y, Chen W, Chen W, Stein A, Weiss LM, Huang Q.
    Am J Hematol; 2010 Jun; 85(6):426-30. PubMed ID: 20513120
    [Abstract] [Full Text] [Related]

  • 22. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU.
    J Clin Oncol; 2008 Nov 01; 26(31):5088-93. PubMed ID: 18768433
    [Abstract] [Full Text] [Related]

  • 23. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
    Carnicer MJ, Lasa A, Buschbeck M, Serrano E, Carricondo M, Brunet S, Aventin A, Sierra J, Di Croce L, Nomdedeu JF.
    Ann Hematol; 2008 Oct 01; 87(10):819-27. PubMed ID: 18587575
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H, Jiang A, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Jan 01; 44(1):55-61. PubMed ID: 22939316
    [Abstract] [Full Text] [Related]

  • 25. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
    Yao DM, Qian J, Lin J, Wang YL, Chen Q, Qian Z, Li Y, Wang CZ, Yang J.
    Leuk Res; 2011 Jul 01; 35(7):957-60. PubMed ID: 21106240
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T, Mueller BU.
    Clin Cancer Res; 2009 Sep 01; 15(17):5303-7. PubMed ID: 19706798
    [Abstract] [Full Text] [Related]

  • 28. Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S.
    Blood Cancer J; 2014 Jul 11; 4(7):e226. PubMed ID: 25014773
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Characterization of CEBPA Mutations and Polymorphisms and their Prognostic Relevance in De Novo Acute Myeloid Leukemia Patients.
    Sarojam S, Raveendran S, Vijay S, Sreedharan J, Narayanan G, Sreedharan H.
    Asian Pac J Cancer Prev; 2015 Jul 11; 16(9):3785-92. PubMed ID: 25987038
    [Abstract] [Full Text] [Related]

  • 32. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with CEBPA Mutation].
    Zhu J, Kang YF, Gao Y, Wang HW, Hao ZH, Wang HW.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr 11; 32(2):335-341. PubMed ID: 38660833
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CEBPA methylation and mutation in myelodysplastic syndrome.
    Wen XM, Hu JB, Yang J, Qian W, Yao DM, Deng ZQ, Zhang YY, Zhu XW, Guo H, Lin J, Qian J.
    Med Oncol; 2015 Jul 11; 32(7):192. PubMed ID: 26025484
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C, van Putten WJ, Kayser S, Verdonck LF, Lübbert M, Ossenkoppele GJ, Germing U, Schmidt-Wolf I, Schlegelberger B, Krauter J, Ganser A, Döhner H, Löwenberg B, Döhner K, Delwel R.
    J Clin Oncol; 2010 Apr 20; 28(12):2101-7. PubMed ID: 20308656
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
    Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, Cayuela JM, Hayette S, Reman O, Contentin N, Bordessoule D, Pautas C, Botton Sd, Revel Td, Terre C, Fenaux P, Thomas X, Castaigne S, Dombret H, Preudhomme C.
    Leukemia; 2012 Jun 20; 26(6):1247-54. PubMed ID: 22289988
    [Abstract] [Full Text] [Related]

  • 40. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M, D'Alò F, Scardocci A, Criscuolo M, Fabiani E, Guidi F, Di Ruscio A, Migliara G, Pagano L, Fianchi L, Chiusolo P, Hohaus S, Leone G, Voso MT.
    Blood Cells Mol Dis; 2010 Oct 15; 45(3):181-5. PubMed ID: 20655775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.